Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The completed study demonstrated significant efficacy with 45% clinical response in the AJM300 group versus 21% in placebo (OR 3.30, 95% CI 1.73-6.29, p=0.00028), good tolerability with similar adverse event rates between groups, and established AJM300 as a potential novel induction therapy for moderately active UC
This reflects the higher calorie deficit available at higher weights
Im 14 pounds down
The kind that makes the first two days after injection miserable
Support healthy blood sugar levels
US$ 28.07
US$ 29.38
US$ 27.08
US$ 25.20
US$ 21.56
US$ 28.53
